10.03.2010 • NewsBayerunder constructionDormagen

Bayer MaterialScience Planning New World-Scale TDI Plant at Dormagen Site

Bayer MaterialScience plans to invest roughly €150 million in a new high-tech production plant for TDI (toluene diisocyanate) at Chempark Dormagen. TDI is a precursor for the production of polyurethane flexible foam. The new plant will have a capacity of 300,000 tons per year and will replace the existing plants in Dormagen and Brunsbüttel. The background behind the project is the company's European-wide optimization of isocyanate production.

The company first presented plans to erect a new TDI production plant in Dormagen in December 2008. The second phase of the project is scheduled to begin in April with the "scoping" hearing, to which the Cologne regional government is invited as the regulatory authority. Subject to political acceptance and approval being granted by the authorities, the world-scale plant will be built on the site of the coal-fired power plant, which will be torn down. The new TDI production plant is currently scheduled to go on stream in 2014. Dormagen will then be the sole Bayer MaterialScience site in Europe for the production of TDI. Plans call for the production of raw materials for polyurethane rigid foams to be expanded in Brunsbüttel.

Company

Logo:

Covestro


51368 Leverkusen
Germany

Company contact







Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read